Product identification
Medicine name:
Aderexa 2.5 mg/25 mg chewable tablets for small dogs and puppies weighing at least 0.5 kg
Aderexa 2.5 mg/25 mg chewable tablets for small dogs and puppies weighing at least 0.5 kg
Active substance:
This information is not available for this product.
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
This information is not available for this product.
Pharmaceutical form:
-
Chewable tablet
Withdrawal period by route of administration:
-
Oral use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP54AB51
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Package description:
- Blister packs consisting of cold formed OPA/Al/PVC foil and aluminium foil.Cardboard box with 1 blister of 2 tablets.
- Blister packs consisting of cold formed OPA/Al/PVC foil and aluminium foil.Cardboard box with 1 blister of 4 tablets.
- Blister packs consisting of cold formed OPA/Al/PVC foil and aluminium foil.Cardboard box with 12 blisters, each blister contains 4 tablets (total 48 tablets).
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Manufacturing sites for batch release:
- Tad Pharma GmbH
- Krka d.d. Novo Mesto
Authorisation number:
- VPA10774/063/001
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0528/001
Concerned member states:
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 28/01/2022